Welcome to the March edition of BioMatrix Abstract!

Welcome to the March edition of BioMatrix Abstract!

BioMatrix Abstract informs readers of our leading efforts in the specialty pharmacy space while providing updates on relevant legislative efforts, research initiatives, and current events in healthcare.


DISCLAIMER: THIS IS NOT MEDICAL OR LEGAL ADVICE. All information, content, and material is for informational purposes only and is not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider or as legal advice. Please consult a physician or other health care professional for your specific health care and/or medical needs or concerns and never disregard professional medical advice or delay in seeking it because of something you have read here or on our website.


March is Bleeding Disorders Awareness Month!?

Securing access to prescribed therapy, resolving insurance issues, and dealing with medically related financial burdens represent some of the health system challenges faced by members of the bleeding disorders community.?

Our Patient Navigation Program supports bleeding disorders patients through these challenges.

Learn more.


Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Signs, Symptoms, and Treatment Options

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a rare autoimmune disorder affecting the nervous system. Here we discuss CIDP signs, symptoms, treatment options, and helpful resources.

Read more.


Insurance Appeal Letter & Template?

Have you been denied insurance coverage for much needed treatment? Use this letter template as a guide to help you or a loved one appeal insurance claim denials.

Access the free download.


BioMatrix on the Move!

Upcoming Events?

Catch up with BioMatrix at these upcoming events. We can't wait to see you!

  • 4/11 to 4/14: Hemophilia Federation of America (HFA) Symposium in Indianapolis, IN?
  • 4/13 to 4/18: American Academy of Neurology (AAN) Annual Meeting in Denver, CO?
  • 4/15 to 4/18: Academy of Managed Care Pharmacy (AMCP) Annual Meeting in New Orleans, LA?
  • 4/25 to 4/28: Coalition for Hemophilia B (CHB) Annual Hybrid Symposium in Dallas, TX?
  • 4/28 to 5/2: Asembia Summit in Las Vegas, NV?


BioMatrix Was Proud to Attend and Support These Meetings

Thanks to all who participated!

  • 3/13: Ultra EMG/AANEM in San Diego, CA?
  • 3/21: San Diego Allergy Society Conference in San Diego, CA?
  • 3/23 to 3/27: National Home Infusion Association in Austin, TX?



Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare but debilitating autoimmune disorder affecting the peripheral nervous system. Although there is no cure for CIDP, various treatment options can help manage symptoms, slow disease progression, and help people keep doing the things they love. ?

Intravenous immunoglobulin (IVIG) therapy can help suppress an overactive immune response, therefore lowering inflammation and reducing symptoms for many patients. ?

BioMatrix helps manage the individual needs of patients requiring IVIG therapy. Knowledgeable pharmacists and care coordination staff guide each patient through the potential medication side effects and, working with the prescribing physician, help manage treatment to reduce the prevalence and severity of relapses.

Learn more about our individualized specialty pharmacy services for patients with CIDP and other neurological conditions.


Specialty Pharmacies

Along with their recent acquisition of BioPlus and Paragon specialty pharmacies, CarelonRx has acquired Kroger pharmacies. Owned by Elevance Health (formerly Anthem Health), CarelonRx is expanding its internal dispensing capabilities and plans to reduce its dependence on pharmacy-giant CVS.

Read more: CarelonRx expands pharmacy footprint with BioPlus and Paragon.


Change Cyberattack

The U.S. Department of Health and Human Services (HHS) met to explore “concrete actions” to support patients impacted by the Change Healthcare cyberattack. A push targeting vulnerable populations in small communities was suggested; support via expedited claims reimbursements to rural and safety-net providers was encouraged. United Health has responded by releasing about $2 billion in advanced payments and has re-launched their payment platform. However, some providers are likely to experience damaged credit reports, especially those relying on the company for financial services.

Read more: HHS urges United Healthcare to respond to claims in timely manner.

Read more: United relaunches Change payment site.

Read more: Small providers could feel credit score hit due to Change cyber attack.


340B

Pharmaceutical manufacturers lost in a recent Arkansas court case where the state was granted the authority to block a manufacturer’s limits on the availability of certain discounted drugs to 340B contract pharmacies. The suit could be picked up by other states looking to push back on the limits the manufacturers have also placed on those 340B programs.

Read more: Pharmaceutical manufacturers lose ability to limit 340B drug dispense.


Never Miss an Edition of BioMatrix Abstract!

Click here to get BioMatrix Abstract sent to your email once monthly!


BioMatrix is a nationwide, independently-owned infusion pharmacy with decades of experience supporting patients on specialty medication.

Visit our website.



要查看或添加评论,请登录

社区洞察

其他会员也浏览了